What do the key players affected by rising prescription drug costs see as its causes and cures? How do they perceive each other and the potential for joint efforts toward solutions? From where they sit, what is working and what is not? And where do we go from here?

To answer these and other questions, Abt Associates interviewed 30 stakeholders across California who play a major role in defining trends and determining the future direction of prescription drug cost and use. Interviewees included:

• Medical directors and pharmacy managers at 13 large medical groups and six managed care organizations;
• Medical directors or human resource managers at five large purchasers, including employers and purchasing cooperatives; and
• Chief financial officers, directors of finance, and directors of pharmacy at five hospitals or health systems.

To capture the government perspective on prescription drug trends, the authors also interviewed a staff member at the California State Legislature.

The full report is available under Document Downloads below.